← Leaderboards
Michael R Wilson
University Of California, San Francisco
$8,552,789
Attributed
$15,622,342
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,622,342 · 6
By mechanism
R01$9,589,478 · 3
U01$2,936,094 · 1
RM1$2,098,085 · 1
K08$998,685 · 1
Top collaborators
- Samuel Jeremy Pleasure10 shared
- Joseph Derisi6 shared
- Nischay Mishra5 shared
- Avindra Nath5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Samuel Jeremy Pleasure$23,213,386
- Satya Dandekar$23,346,836
- Arthur Weiss$25,258,536
- Robert M Stroud$50,842,733
- Trey Ideker$62,370,509
Others in their field
Other Emerging Leaders on “Cerebrospinal Fluid”
- Maria C Carrillo · Indiana University Indianapolis$19,489,876
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Ganesh M Babulal · Washington University$12,351,706
- Michal Engelman · University Of Wisconsin-Madison$11,072,310
- Colin Masters · University Of Melbourne$10,651,748
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
Research focus
Cerebrospinal FluidBiological MarkersAutoantibodiesSyndromeSamplingDiagnosticPathogenesisScientistCohortMicrobialNext Generation SequencingMolecularInflammatoryEncephalitisMetagenomicsUniversitiesInfectionPatternNeuroinflammationAutoantigensDiagnosisAntigensAntibodiesAffect
Grant awards (25)
Antigen-directed therapies for autoantibody associated neuroinflammatory diseases.$2,098,085
RM1 · FY2025 · NS
Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases$583,466
U01 · FY2025 · NS · contact PI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19$432,694
R01 · FY2025 · NS · contact PI
Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets$767,107
R01 · FY2024 · MH · contact PI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19$575,015
R01 · FY2024 · NS · contact PI
Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases$566,387
U01 · FY2024 · NS · contact PI
Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets$767,107
R01 · FY2023 · MH · contact PI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics$682,045
R01 · FY2023 · AI · contact PI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19$629,459
R01 · FY2023 · NS · contact PI
Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases$584,303
U01 · FY2023 · NS · contact PI
Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets$767,107
R01 · FY2022 · MH · contact PI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics$678,481
R01 · FY2022 · AI · contact PI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19$623,479
R01 · FY2022 · NS · contact PI
Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases$584,664
U01 · FY2022 · NS · contact PI
Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets$767,107
R01 · FY2021 · MH · contact PI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics$682,642
R01 · FY2021 · AI · contact PI
Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases$617,274
U01 · FY2021 · NS · contact PI
Next-Generation Diagnostics for Acute Encephalitis$199,737
K08 · FY2021 · NS · contact PI
Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets$806,237
R01 · FY2020 · MH · contact PI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics$686,519
R01 · FY2020 · AI · contact PI
Next-Generation Diagnostics for Acute Encephalitis$199,737
K08 · FY2020 · NS · contact PI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics$724,479
R01 · FY2019 · AI · contact PI
Next-Generation Diagnostics for Acute Encephalitis$199,737
K08 · FY2019 · NS · contact PI
Next-Generation Diagnostics for Acute Encephalitis$199,737
K08 · FY2018 · NS · contact PI
Next-Generation Diagnostics for Acute Encephalitis$199,737
K08 · FY2017 · NS · contact PI